US Patent 12123032 CRISPR enzyme mutations reducing off-target effects

Patent

US Patent 10876100 Crispr enzyme mutations reducing off-target effects

US Patent 10781444 Functional genomics using CRISPR-Cas systems, compositions, methods, screens and applications thereof

US Patent 10851357 Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders

US Patent 10930367 Methods, models, systems, and apparatus for identifying target sequences for Cas enzymes or CRISPR-Cas systems for target sequences and conveying results thereof

US Patent 10941395 Method for gene editing

US Patent 11116729 Drug delivery systems containing oxidized cholesterols

US Patent 11559588 Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders

US Patent 11578312 Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation

US Patent 7601492 Genome mapping of functional DNA elements and cellular proteins

US Patent 7691995 In vivo production of small interfering RNAS that mediate gene silencing

United States Patent and Trademark Office

Nancy J Leith